- Standardized Combination Antibiotic Treatment of Mycobacterium avium Complex Lung Disease
-
Sim YS, Park HY, Jeon K, Suh GY, Kwon OJ, Koh WJ
- KMID: 1779636
- Yonsei Med J.
- 2010 Nov;51(6):888-894.
- doi: 10.3349/ymj.2010.51.6.888
PURPOSE: The optimal treatment regimen for Mycobacterium avium complex (MAC) lung disease has not yet been fully established. We evaluated the efficacy of standardized combination antibiotic therapy and the factors... -
- CITED
-
- Close
- SHARE
-
- Close
- Sequential Bilateral Lung Resection in a Patient with Mycobacterium Abscessus Lung Disease Refractory to Medical Treatment
-
Lee SH, Min JW, Um SW, Han SS, Han SK, Shim YS, Yim JJ
- KMID: 1779621
- Yonsei Med J.
- 2010 Jan;51(1):141-144.
- doi: 10.3349/ymj.2010.51.1.141
Mycobacterium abscessus (M. abscessus) is the second most common nontuberculous mycobacteria (NTM) in South Korea. Nevertheless, the diagnosis and treatment of M. abscessus lung disease can be problematic. Surgical resection... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of sevoflurane on tight junction protein expression and PKC-alpha translocation after pulmonary ischemia-reperfusion injury
-
Chai J, Long B, Liu X, Li Y, Han N, Zhao P, Chen W
- KMID: 2155421
- Exp Mol Med.
- 2015 Jun;47(6):e167.
- doi: 10.1038/emm.2015.27
Pulmonary dysfunction caused by ischemia-reperfusion injury is the leading cause of mortality in lung transplantation. We aimed to investigate the effects of sevoflurane pretreatment on lung permeability, tight junction protein... -
- CITED
-
- Close
- SHARE
-
- Close
- Successful Treatment of Mycobacterium celatum Pulmonary Disease in an Immunocompetent Patient Using Antimicobacterial Chemotherapy and Combined Pulmonary Resection
-
Jun HJ, Lee NY, Kim J, Koh WJ
- KMID: 1779652
- Yonsei Med J.
- 2010 Nov;51(6):980-983.
- doi: 10.3349/ymj.2010.51.6.980
Mycobacterium celatum is a nontuberculous mycobacterium that rarely causes pulmonary disease in immunocompetent subjects. We describe the successful treatment of M. celatum lung disease with antimicobacterial chemotherapy and combined pulmonary... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment Outcome of Combination Therapy Including Clarithromycin for Mycobacterium avium Complex Pulmonary Disease
-
Kim EY, Chi SY, Oh IJ, Kim KS, Kim YI, Lim SC, Kim YC, Kwon YS
- KMID: 1036151
- Korean J Intern Med.
- 2011 Mar;26(1):54-59.
- doi: 10.3904/kjim.2011.26.1.54
BACKGROUND/AIMS: The frequency of nontuberculous mycobacteria pulmonary disease in HIV-negative patients is increasing; the most common pathogen in Korea is the Mycobacterium avium complex (MAC). However, few studies have evaluated... -
- CITED
-
- Close
- SHARE
-
- Close
- Decreasing Incidence of Chronic Lung Disease Despite the Gradual Reduction of Postnatal Dexamethasone Use in Very Low Birth Weight Infants
-
Choi CW, Hwang JH, Shim JW, Ko SY, Lee EK, Kim SS, Chang YS, Park WS, Shin SM
- KMID: 2157678
- J Korean Med Sci.
- 2004 Aug;19(4):514-518.
- doi: 10.3346/jkms.2004.19.4.514
Dexamethasone has been widely used in very low birth weight infants (VLBWI) weighing less than 1,500 g at birth for the prevention or treatment of chronic lung disease (CLD). Recently,... -
- CITED
-
- Close
- SHARE
-
- Close
